U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796322) titled 'Clinical Evaluation of Non-invasive Blood Glucose Meter' on Jan. 13.
Brief Summary: This trial is a prospective, multicenter, non-randomized, open-label, self-controlled, paired design clinical study, which will be conducted in 3 research centers, with a total of 210 subjects enrolled, including diabetic patients aged 18 years and above and some healthy subjects. After screening, each eligible subject will have their blood glucose measured simultaneously at specified time points using three methods: non-invasive blood glucose meter (the experimental group), fully automatic laboratory biochemical analyzer (the primary control group) ...